Loading…
The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis, with NASH recently shown as an important cause of hep...
Saved in:
Published in: | International journal of molecular sciences 2020-05, Vol.21 (11), p.3863 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3 |
container_end_page | |
container_issue | 11 |
container_start_page | 3863 |
container_title | International journal of molecular sciences |
container_volume | 21 |
creator | Fujii, Hideki Kawada, Norifumi Japan Study Group Of Nafld Jsg-Nafld |
description | Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis, with NASH recently shown as an important cause of hepatocellular carcinoma (HCC). There is a close relationship between insulin resistance (IR) and NAFLD, with a five-fold higher prevalence of NAFLD in patients with type 2 diabetes (T2DM) compared to that in patients without T2DM. IR is involved in the progression of disease conditions such as steatosis and NASH, as well as hepatic fibrosis progression. The mechanisms underlying these processes involve genetic factors, hepatic fat accumulation, alterations in energy metabolism, and inflammatory signals derived from various cell types including immune cells. In NASH-associated fibrosis, the principal cell type responsible for extracellular matrix production is the hepatic stellate cell (HSC). HSC activation by IR involves "direct" and "indirect" pathways. This review will describe the molecular mechanisms of inflammation and hepatic fibrosis in IR, the relationship between T2DM and hepatic fibrosis, and the relationship between T2DM and HCC in patients with NAFLD. |
doi_str_mv | 10.3390/ijms21113863 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c3223d68522949c5b43c9404ff157097</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c3223d68522949c5b43c9404ff157097</doaj_id><sourcerecordid>2408951776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3</originalsourceid><addsrcrecordid>eNpdkcFrFDEUh4NYbG29eZaAFw-uTfIyM8lFKNXqwtJCqeeQSV66WWYnNZkp9L83dmvZesoj7-N7yfsR8p6zLwCancbNtgjOOagWXpEjLoVYMNZ2r_fqQ_K2lA1jAkSj35BDEFI1CtQRubpZI71OA9IU6HIs8xBHeo0llsmODqkdPf0WbY8TFlpbl2m0g0vrNERHL-w0PdBVvMdcoYK24Ak5CHYo-O7pPCa_Lr7fnP9crK5-LM_PVgvXSDktQrDSKwaddUH4VmnJlBbcSWDolAu970GCZ85b4Zi0jfbetgIl8ywEgXBMljuvT3Zj7nLc2vxgko3m8SLlW2PzFN2AxoEQUGc0QmipXdNLcHWeDIE3HdNddX3due7mfove4ThlO7yQvuyMcW1u073pgAsNvAo-PQly-j1jmcw2FofDYEdMczFCMs21BM4q-vE_dJPmXHf6SCnd8K5rK_V5R7mcSskYnh_DmfmbutlPveIf9j_wDP-LGf4ATXynlA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2408951776</pqid></control><display><type>article</type><title>The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease</title><source>ProQuest - Publicly Available Content Database</source><source>PubMed Central</source><creator>Fujii, Hideki ; Kawada, Norifumi ; Japan Study Group Of Nafld Jsg-Nafld</creator><creatorcontrib>Fujii, Hideki ; Kawada, Norifumi ; Japan Study Group Of Nafld Jsg-Nafld ; Japan Study Group of NAFLD (JSG-NAFLD)</creatorcontrib><description>Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis, with NASH recently shown as an important cause of hepatocellular carcinoma (HCC). There is a close relationship between insulin resistance (IR) and NAFLD, with a five-fold higher prevalence of NAFLD in patients with type 2 diabetes (T2DM) compared to that in patients without T2DM. IR is involved in the progression of disease conditions such as steatosis and NASH, as well as hepatic fibrosis progression. The mechanisms underlying these processes involve genetic factors, hepatic fat accumulation, alterations in energy metabolism, and inflammatory signals derived from various cell types including immune cells. In NASH-associated fibrosis, the principal cell type responsible for extracellular matrix production is the hepatic stellate cell (HSC). HSC activation by IR involves "direct" and "indirect" pathways. This review will describe the molecular mechanisms of inflammation and hepatic fibrosis in IR, the relationship between T2DM and hepatic fibrosis, and the relationship between T2DM and HCC in patients with NAFLD.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21113863</identifier><identifier>PMID: 32485838</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Animals ; Biopsy ; Cell activation ; Cirrhosis ; Cytokines ; Diabetes ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus - epidemiology ; Diabetes Mellitus - genetics ; Diabetes Mellitus - metabolism ; Energy metabolism ; Extracellular matrix ; Fatty liver ; Fibrosis ; Genetic factors ; Glucose ; hepatic fibrosis ; Hepatocellular carcinoma ; Humans ; Hyperglycemia ; Immune system ; Inflammation ; Insulin ; Insulin Resistance ; Kinases ; Liver ; Liver cancer ; Liver cirrhosis ; Liver diseases ; Metabolism ; Molecular modelling ; Mortality ; Non-alcoholic Fatty Liver Disease - epidemiology ; Non-alcoholic Fatty Liver Disease - genetics ; Non-alcoholic Fatty Liver Disease - metabolism ; Obesity ; Proteins ; Review ; Steatosis ; stellate cell ; Tumor necrosis factor-TNF</subject><ispartof>International journal of molecular sciences, 2020-05, Vol.21 (11), p.3863</ispartof><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3</citedby><cites>FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3</cites><orcidid>0000-0003-1267-9623</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2408951776/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2408951776?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32485838$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fujii, Hideki</creatorcontrib><creatorcontrib>Kawada, Norifumi</creatorcontrib><creatorcontrib>Japan Study Group Of Nafld Jsg-Nafld</creatorcontrib><creatorcontrib>Japan Study Group of NAFLD (JSG-NAFLD)</creatorcontrib><title>The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis, with NASH recently shown as an important cause of hepatocellular carcinoma (HCC). There is a close relationship between insulin resistance (IR) and NAFLD, with a five-fold higher prevalence of NAFLD in patients with type 2 diabetes (T2DM) compared to that in patients without T2DM. IR is involved in the progression of disease conditions such as steatosis and NASH, as well as hepatic fibrosis progression. The mechanisms underlying these processes involve genetic factors, hepatic fat accumulation, alterations in energy metabolism, and inflammatory signals derived from various cell types including immune cells. In NASH-associated fibrosis, the principal cell type responsible for extracellular matrix production is the hepatic stellate cell (HSC). HSC activation by IR involves "direct" and "indirect" pathways. This review will describe the molecular mechanisms of inflammation and hepatic fibrosis in IR, the relationship between T2DM and hepatic fibrosis, and the relationship between T2DM and HCC in patients with NAFLD.</description><subject>Animals</subject><subject>Biopsy</subject><subject>Cell activation</subject><subject>Cirrhosis</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetes Mellitus - genetics</subject><subject>Diabetes Mellitus - metabolism</subject><subject>Energy metabolism</subject><subject>Extracellular matrix</subject><subject>Fatty liver</subject><subject>Fibrosis</subject><subject>Genetic factors</subject><subject>Glucose</subject><subject>hepatic fibrosis</subject><subject>Hepatocellular carcinoma</subject><subject>Humans</subject><subject>Hyperglycemia</subject><subject>Immune system</subject><subject>Inflammation</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Kinases</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Liver cirrhosis</subject><subject>Liver diseases</subject><subject>Metabolism</subject><subject>Molecular modelling</subject><subject>Mortality</subject><subject>Non-alcoholic Fatty Liver Disease - epidemiology</subject><subject>Non-alcoholic Fatty Liver Disease - genetics</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>Obesity</subject><subject>Proteins</subject><subject>Review</subject><subject>Steatosis</subject><subject>stellate cell</subject><subject>Tumor necrosis factor-TNF</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkcFrFDEUh4NYbG29eZaAFw-uTfIyM8lFKNXqwtJCqeeQSV66WWYnNZkp9L83dmvZesoj7-N7yfsR8p6zLwCancbNtgjOOagWXpEjLoVYMNZ2r_fqQ_K2lA1jAkSj35BDEFI1CtQRubpZI71OA9IU6HIs8xBHeo0llsmODqkdPf0WbY8TFlpbl2m0g0vrNERHL-w0PdBVvMdcoYK24Ak5CHYo-O7pPCa_Lr7fnP9crK5-LM_PVgvXSDktQrDSKwaddUH4VmnJlBbcSWDolAu970GCZ85b4Zi0jfbetgIl8ywEgXBMljuvT3Zj7nLc2vxgko3m8SLlW2PzFN2AxoEQUGc0QmipXdNLcHWeDIE3HdNddX3due7mfove4ThlO7yQvuyMcW1u073pgAsNvAo-PQly-j1jmcw2FofDYEdMczFCMs21BM4q-vE_dJPmXHf6SCnd8K5rK_V5R7mcSskYnh_DmfmbutlPveIf9j_wDP-LGf4ATXynlA</recordid><startdate>20200529</startdate><enddate>20200529</enddate><creator>Fujii, Hideki</creator><creator>Kawada, Norifumi</creator><creator>Japan Study Group Of Nafld Jsg-Nafld</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1267-9623</orcidid></search><sort><creationdate>20200529</creationdate><title>The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease</title><author>Fujii, Hideki ; Kawada, Norifumi ; Japan Study Group Of Nafld Jsg-Nafld</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Biopsy</topic><topic>Cell activation</topic><topic>Cirrhosis</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetes Mellitus - genetics</topic><topic>Diabetes Mellitus - metabolism</topic><topic>Energy metabolism</topic><topic>Extracellular matrix</topic><topic>Fatty liver</topic><topic>Fibrosis</topic><topic>Genetic factors</topic><topic>Glucose</topic><topic>hepatic fibrosis</topic><topic>Hepatocellular carcinoma</topic><topic>Humans</topic><topic>Hyperglycemia</topic><topic>Immune system</topic><topic>Inflammation</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Kinases</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Liver cirrhosis</topic><topic>Liver diseases</topic><topic>Metabolism</topic><topic>Molecular modelling</topic><topic>Mortality</topic><topic>Non-alcoholic Fatty Liver Disease - epidemiology</topic><topic>Non-alcoholic Fatty Liver Disease - genetics</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>Obesity</topic><topic>Proteins</topic><topic>Review</topic><topic>Steatosis</topic><topic>stellate cell</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fujii, Hideki</creatorcontrib><creatorcontrib>Kawada, Norifumi</creatorcontrib><creatorcontrib>Japan Study Group Of Nafld Jsg-Nafld</creatorcontrib><creatorcontrib>Japan Study Group of NAFLD (JSG-NAFLD)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest_Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fujii, Hideki</au><au>Kawada, Norifumi</au><au>Japan Study Group Of Nafld Jsg-Nafld</au><aucorp>Japan Study Group of NAFLD (JSG-NAFLD)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-05-29</date><risdate>2020</risdate><volume>21</volume><issue>11</issue><spage>3863</spage><pages>3863-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis, with NASH recently shown as an important cause of hepatocellular carcinoma (HCC). There is a close relationship between insulin resistance (IR) and NAFLD, with a five-fold higher prevalence of NAFLD in patients with type 2 diabetes (T2DM) compared to that in patients without T2DM. IR is involved in the progression of disease conditions such as steatosis and NASH, as well as hepatic fibrosis progression. The mechanisms underlying these processes involve genetic factors, hepatic fat accumulation, alterations in energy metabolism, and inflammatory signals derived from various cell types including immune cells. In NASH-associated fibrosis, the principal cell type responsible for extracellular matrix production is the hepatic stellate cell (HSC). HSC activation by IR involves "direct" and "indirect" pathways. This review will describe the molecular mechanisms of inflammation and hepatic fibrosis in IR, the relationship between T2DM and hepatic fibrosis, and the relationship between T2DM and HCC in patients with NAFLD.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32485838</pmid><doi>10.3390/ijms21113863</doi><orcidid>https://orcid.org/0000-0003-1267-9623</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2020-05, Vol.21 (11), p.3863 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_c3223d68522949c5b43c9404ff157097 |
source | ProQuest - Publicly Available Content Database; PubMed Central |
subjects | Animals Biopsy Cell activation Cirrhosis Cytokines Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus - epidemiology Diabetes Mellitus - genetics Diabetes Mellitus - metabolism Energy metabolism Extracellular matrix Fatty liver Fibrosis Genetic factors Glucose hepatic fibrosis Hepatocellular carcinoma Humans Hyperglycemia Immune system Inflammation Insulin Insulin Resistance Kinases Liver Liver cancer Liver cirrhosis Liver diseases Metabolism Molecular modelling Mortality Non-alcoholic Fatty Liver Disease - epidemiology Non-alcoholic Fatty Liver Disease - genetics Non-alcoholic Fatty Liver Disease - metabolism Obesity Proteins Review Steatosis stellate cell Tumor necrosis factor-TNF |
title | The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T03%3A03%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Insulin%20Resistance%20and%20Diabetes%20in%20Nonalcoholic%20Fatty%20Liver%20Disease&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Fujii,%20Hideki&rft.aucorp=Japan%20Study%20Group%20of%20NAFLD%20(JSG-NAFLD)&rft.date=2020-05-29&rft.volume=21&rft.issue=11&rft.spage=3863&rft.pages=3863-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21113863&rft_dat=%3Cproquest_doaj_%3E2408951776%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2408951776&rft_id=info:pmid/32485838&rfr_iscdi=true |